[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Suzhou Care-Real Medical Technology Co., Ltd.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":122},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,5,0,[8,39,59,81,103],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":38},"100595138","post-market-clinical-follow-up-study-plan-for-cartridges-of-disposable-endoscopic-linear-cutting-staplers-100595138",false,"NCT07028554","Post-Market Clinical Follow-Up Study Plan for Cartridges of Disposable Endoscopic Linear Cutting Staplers","Inclusion Criteria:\n\n1. Age≥18 years old, gender unlimited;\n2. The surgery type shall be open or endoscopic surgery;\n3. The departments of surgical procedures: general, gynecologic, urologic and thoracic surgical procedures;\n4. Investigational devices listed in this PMCF plan must be used during surgical procedures.\n\nExclusion Criteria:\n\n1. Patients with surgical contraindications to the product, e.g. use the instruments on large arteries, on ischemic or necrotic tissue, use the device on tissues with a compression thickness out of the device range;\n2. Concomitant with similar devices (staplers\u002Freloads\u002Fcartridges, etc.) for resection, transection and anastomosis of surgical organ or tissues;\n3. The operation record is incomplete, and the information related to the main indicators cannot be extracted.","ALL","18 Years",{"count":18,"type":19},300,"ESTIMATED","OBSERVATIONAL","Cartridges of Disposable Endoscopic Linear Cutting Staplers, Disposable Powered Endoscopic Linear Cutting Staplers and Disposable Endoscopic Linear Cutting Staplers manufactured by Ningbo Verykind Medical Device Co., Ltd. have marketed in many countries or area for many years. The investigational devices are intended for transection, resection, and\u002For creation of anastomoses. The instruments have application in multiple open or minimally invasive general, gynecologic, urologic and thoracic surgical procedures.\n\nIn order to confirm the safety and performance of the products, as well as the continued safety and clinical performance of the implant (the staple) during the clinical follow-up period, monitor the identified side-effects, contraindications and identify previously unknown side-effects, and ensure the continued acceptability of the benefit-risk ratio, Investigators proactively collect and evaluate clinical data from different regions, including of Italy, Brazil and Chile, where the device has been marketed, and conduct PMCF studies.",[23,24,25],"the Transection of Tissues","the Resection of Tissues","the Creation of Anastomoses","RECRUITING","2025-06-11",{"date":29,"type":30},"2025-06-19","ACTUAL",{"date":32,"type":30},"2025-01-10",{"date":34,"type":19},"2025-07-15",{"name":36,"class":37},"Suzhou Care-Real Medical Technology Co., Ltd.","OTHER",1,{"id":40,"slug":41,"hasResults":11,"nctId":42,"briefTitle":43,"officialTitle":43,"acronym":4,"eligibilityCriteria":44,"healthyVolunteers":11,"sex":15,"minAge":4,"maxAge":4,"enrollmentInfo":45,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":47,"conditions":48,"keywords":4,"overallStatus":50,"whyStopped":4,"lastUpdateSubmitDate":51,"lastUpdatePostDateStruct":52,"startDateStruct":54,"completionDateStruct":56,"leadSponsor":58,"locationsCount":38},"100568114","post-market-clinical-follow-up-study-plan-for-disposable-endoscopic-linear-cutter-stapler-100568114","NCT06677008","Post-market Clinical Follow-up Study Plan for Disposable Endoscopic Linear Cutter Stapler","Inclusion Criteria:\n\n* Age unlimited and gender unlimited;\n* The surgery type shall be endoscopic surgery;\n* The departments of surgical procedures: general and thoracic surgical procedures;\n* Investigational devices of all the models of the staplers and its cartridge listed in Section 2.3.\n\nExclusion Criteria:\n\n* Patients undergoing surgery for contraindications to the product, such as severe mucosal edema, non-observation of hemostatic sites for surgery or off-label use, such as liver and spleen;\n* Combined with other similar products (stapler) for resection, transection and anastomosis of the surgical site;\n* Surgery record is incomplete, unable to extract main indicators related information.",{"count":46,"type":19},302,"This study conducted a Post-Market Clinical Follow-Up study (PMCF) to evaluate the safety and effectiveness of the disposable endoscopic linear cutter stapler produced by Changzhou Ankang Medical Instrument Co., Ltd., through a retrospective analysis of the clinical data, to evaluate the safety and effectiveness of soft tissue resection, transection and anastomosis.",[49],"The Expeditious Transection\u002Fresection of Tissues and Creation of Anastomoses","NOT_YET_RECRUITING","2024-11-04",{"date":53,"type":30},"2024-11-06",{"date":55,"type":19},"2024-11-15",{"date":57,"type":19},"2025-02-28",{"name":36,"class":37},{"id":60,"slug":61,"hasResults":11,"nctId":62,"briefTitle":63,"officialTitle":63,"acronym":4,"eligibilityCriteria":64,"healthyVolunteers":11,"sex":15,"minAge":4,"maxAge":4,"enrollmentInfo":65,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":67,"conditions":68,"keywords":70,"overallStatus":50,"whyStopped":4,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":38},"100558757","post-market-clinical-follow-up-of-disposable-endoscope-linear-cutting-staplers-and-components-100558757","NCT06555276","Post-market Clinical Follow-up of Disposable Endoscope Linear Cutting Staplers and Components","Inclusion Criteria:\n\n* gender unlimited, age unlimited ② open or endoscopic surgery ③ resection, transection and anastomosis of lung, bronchial tissue, stomach and intestines.\n\n  * use the study device during surgery\n\nExclusion Criteria:\n\n* patients with contraindications to the product, such as severe mucosal edema, operation of the hemostatic site that cannot be observed, or off-label use of the liver and spleen;\n\n  * combined with other similar products (staplers) for surgical site excision, transsection and anastomosis; ③ surgical records are incomplete, and information related to major indicators cannot be extracted; ④ other situations that the researcher considers inappropriate for inclusion in the study.",{"count":66,"type":19},195,"This is a multi-center and retrospective cohort study to evaluate the efficacy and safety of disposable linear cutting staplers and components in soft tissue resection, transection and anastomosis.",[69],"Gastric Disease",[71,72],"stapler","anastomosis","2024-08-12",{"date":75,"type":30},"2024-08-15",{"date":77,"type":19},"2024-08-20",{"date":79,"type":19},"2024-12-31",{"name":36,"class":37},{"id":82,"slug":83,"hasResults":11,"nctId":84,"briefTitle":85,"officialTitle":86,"acronym":4,"eligibilityCriteria":87,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":88,"targetDuration":4,"studyType":90,"phases":91,"briefSummary":93,"conditions":94,"keywords":4,"overallStatus":50,"whyStopped":4,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":99,"completionDateStruct":100,"leadSponsor":102,"locationsCount":4},"100555567","a-clinical-investigation-to-evaluate-the-safety-and-efficacy-of-zirconia-ceramic-blocks-for-use-in-dental-prostheses-100555567","NCT06513767","A Clinical Investigation to Evaluate the Safety and Efficacy of Zirconia Ceramic Blocks for Use in Dental Prostheses.","A Prospective, Multicentre, Single-group, Target-value Clinical Investigation Evaluating the Safety and Efficacy of Zirconia Ceramic Blocks for All-ceramic Dentures for Use in Dental Prostheses.","Inclusion Criteria:\n\n1. Age ≥ 18 years old, gender is not limited;\n2. Patients with permanent teeth who were judged by the investigator to be expected to have dental prostheses using zirconia materials;\n3. Subjects volunteered and signed an informed consent form.\n\nExclusion Criteria:\n\n1. Allergy to zirconia ceramic materials or a history of extensive allergies;\n2. Patients with oral mucosal ulcers;\n3. Patients presents with a significant, uncontrolled, systemic disease, encompassing, but not limited to, cardiovascular disease, endocrine or metabolic disease, and immune system disease, among others;\n4. Pregnant or breastfeeding, or those planning to become pregnant during the investigation period;\n5. Participation in another clinical investigation within 3 months;\n6. Patients with mental disorders and a lack of autonomy;\n7. Meets other conditions that, in the opinion of the investigator, make participation in this clinical investigation inappropriate.",{"count":89,"type":19},150,"INTERVENTIONAL",[92],"NA","The goal of this clinical trial is to use the investigational device (Zirconia Dental Ceramics) to perform dental prosthesis in Patients with permanent teeth. The main question it aims to answer is:\n\nIs the safety and efficacy of the investigational device (Zirconia Dental Ceramics) adequate to meet the requirements for clinical use?\n\nParticipants will use the investigational device (Zirconia Dental Ceramics) to perform dental prosthesis and then complete a 12-month follow-up after prostheses. During the follow-up period，participants will assess their satisfaction，while the investigator will assess the efficacy indices of prosthesis survival rate, prosthesis success rate and prosthesis quality.",[95],"Dental Prosthesis","2024-07-17",{"date":98,"type":30},"2024-07-22",{"date":75,"type":19},{"date":101,"type":19},"2025-12-20",{"name":36,"class":37},{"id":104,"slug":105,"hasResults":11,"nctId":106,"briefTitle":107,"officialTitle":108,"acronym":4,"eligibilityCriteria":109,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":110,"targetDuration":4,"studyType":90,"phases":112,"briefSummary":113,"conditions":114,"keywords":4,"overallStatus":50,"whyStopped":4,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":116,"startDateStruct":118,"completionDateStruct":119,"leadSponsor":121,"locationsCount":4},"100545804","a-clinical-trial-to-evaluate-the-safety-and-efficacy-of-single-use-fibrous-ring-sutures-for-the-suture-of-fibrous-ring-incision-after-nucleus-pulposus-removal-100545804","NCT06386666","A Clinical Trial to Evaluate the Safety and Efficacy of Single-use Fibrous Ring Sutures for the Suture of Fibrous Ring Incision After Nucleus Pulposus Removal","A Prospective, Multicenter, Single-group, Target-value Clinical Trial to Evaluate the Safety and Efficacy of Single-use Annular Sutures for Annular Incisions Following Nucleus Pulposus Removal","Inclusion Criteria:\n\n1. Age ≥18 years old, gender unlimited;\n2. Meet the diagnosis of lumbar disc herniation (refer to the Guidelines for Diagnosis and Treatment of Lumbar disc herniation), and expect to undergo single-level disc nucleus pulposus extraction;\n3. The history of lumbar disc herniation is more than 6 weeks, and systematic conservative treatment is ineffective；\n4. ODI index ≥20 points;\n5. In the VAS score of bilateral lower limbs, at least one side was ≥4 points;\n6. The score of the three evaluation indicators according to the modified Pfirrmann grade, age and disc height is no more than 7 points (see Annex 1 for the criteria);\n7. Voluntarily participate and sign informed consent;\n8. Be able to communicate well with research doctors, have good compliance, and can follow the requirements of clinical research.\n\nExclusion Criteria:\n\n1. Laboratory examination (blood routine examination, blood biochemistry, coagulation function and blood pregnancy, etc.), imaging examination (MRI) and vital signs examination have abnormal results with clinical significance, and the researchers believe that they are not suitable for inclusion;\n2. Active local or systemic infection;\n3. Patients with lumbar tumors and\u002For spinal malformations;\n4. Imaging showed calcification of the posterior longitudinal ligament;\n5. A history of serious diseases of important organs (such as cardiovascular system, liver, lung, kidney and nervous system);\n6. There are autoimmune diseases or abnormal coagulation function;\n7. Previous or planned surgical procedures to fuse or stabilize the lumbar spine during the trial;\n8. Intraoperative exploration of the location of the annulus fibriatus could not satisfy the requirement that the needle entry point was more than 2mm away from the margin of the annulus fibriatus;\n9. Pregnant or lactating women, or those who have a pregnancy plan during the trial period;\n10. Those who are participating in other clinical trials at the same time;\n11. Other situations that the researcher considers inappropriate to participate in this study.",{"count":111,"type":19},135,[92],"The objective of this clinical trial was to evaluate the safety and effectiveness of single-use annular sutures for the closure of annular incisions after nucleus pulposus removal. Participants used single-use annular sutures to close the annular fibers. The success rate of suture, reduction value of annulus, proportion of annulus reduction, intraoperative blood loss, suture time, VAS pain score (low back, bilateral lower extremities), Oswestry index (ODI index), and Short were evaluated The effectiveness evaluation results of Form-12 health survey (SF-12 score), treatment success rate, device defects, product operation satisfaction, and safety evaluation results of recurrence rate, adverse events, and serious adverse events were used to verify the safety and effectiveness of disposable fibrillar suture for annular incision suture after nucleus pulposus removal.",[115],"Intervertebral Disc Disorder",{"date":117,"type":30},"2024-07-19",{"date":75,"type":19},{"date":120,"type":19},"2025-11-15",{"name":36,"class":37},""]